Together, our data demonstrated that inflammation potentiates Samd9l-Mut phenotypes, in particular, pancytopenia with lymphopenia, corresponding to clinical observations in patients with SAMD9L mutations (13, 29–31). This evidence concerns the gene SAMD9L and lymphopenia.